Nilotinib vs. Nilotinib Plus Interferon α Induction and Nilotinib or Interferon α Maintenance Therapy for Newly Diagnosed BCR-ABL Positive Chronic Myeloid Leukemia Patients in Chronic Phase: Interim Analysis of the Tiger (CML V) Trial